A new lead for autoimmune disease
Friday, June 5, 2009 - 12:21
in Health & Medicine
A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI), along with the Harvard School of Dental Medicine. In the 5 June edition of Science, they show that a small-molecule compound known as halofuginone inhibits the development of Th17 cells, immune cells recently recognised as important players in autoimmune disease, without altering other kinds of T cells involved in normal immune function. They further demonstrate that halofuginone reduces disease pathology in a mouse model of autoimmunity...
Read the whole article on Science Centric
More from Science Centric
Related
- A new lead for autoimmune diseaseThu, 4 Jun 2009, 14:37:30 EDT
- NIH scientists find a novel mechanism that controls the development of autoimmunityWed, 13 Aug 2008, 14:15:28 EDT
- How cells die determines whether immune system mounts responseThu, 17 Jul 2008, 12:35:45 EDT
- Narcolepsy is an autoimmune disorder, Stanford researcher saysSun, 3 May 2009, 13:51:48 EDT
- B cells can act alone in autoimmune disease, Yale researchers reportThu, 7 Aug 2008, 15:56:58 EDT